Aberration, Corneal Wavefront
7
1
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Immediate Effects of Lipid-Based and Non-Lipid Artificial Tears on Corneal Aberrations
Clinical Investigation for a Multifunction Ophthalmic Measurement Device
Wavefront Guided Scleral Lenses for Keratoconus and Irregular Astigmatism
Monofocal Extended Range of Vision (MERoV) Study
Correlation of Angle Kappa , Corneal High Order Aberrations and Total Eye Aberrations in Various Refractive Errors
Ocular Changes With Alpha-2 Receptor Agonist.
Chromatic and Monochromatic Optical Aberrations After Corneal Refractive Surgery